Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guideline – Biliary Tract Cancer

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Ann Oncol. 2023;34(2):127-140.
Vogel A, Bridgewater J, Edeline J, et al, on behalf of the ESMO Guidelines Committee

  • This ESMO Clinical Practice Guideline provides key recommendations for managing biliary tract cancer.
  • The guideline covers clinical and pathological diagnosis, staging and risk assessment, treatment and follow-up.
  • A treatment and management algorithm for locoregional and advanced/metastatic disease is provided.
  • ESCAT scores are given to describe the evidence level for genomic alterations as biomarkers for using targeted therapies.
  • Recommendations are based on available scientific data and the authors’ collective expert opinion.

ESMO Guidelines: Real World Cases - Webinar Series - Biliary Tract Cancer

ESMO-Guidelines-Real -World-Cases-Webinar-Series-General-1000x1000px

27 February 2024 at 18:30 CET

Join the experts developing and implementing the ESMO Guidelines

Register now

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.